Peer-reviewedCC BYBiomedicines
Pan-Cancer Analysis Identifies LUC7L2 as a Prognostic Biomarker and Potential Functional Regulator of Prostate Cancer Progression
4 affiliations
- 1Department of Oncology, Dongguan Hospital of , Dongguan 523000, China; (J.Y.); (H.W.)
- 2Department of Surgery, Dongguan Hospital of , Dongguan 523000, China; (P.Z.); (G.L.)
- 3Department of Laboratory Medicine, Dongguan Hospital of , Dongguan 523000, China;
- 4Department of Radiation Oncology, Dongguan Hospital of , Dongguan 523000, China;
Related
- Pan-cancer analysis identifies ANGPT4 as a potential prognostic biomarker associated with the tumor microenvironment in kidney renal clear cell carcinoma
- Pan-cancer analysis identifies KPNA7 as a prognostic and immune-related biomarker with functional relevance in gastric cancer.
- Multi-omics integration identifies PON2 as a prognostic biomarker and mediator of tumor microenvironment remodeling in gallbladder cancer
- Multi-omics profiling uncovers diagnostic biomarker panel, progression-associated subtypes, and prognostic signature in pediatric mitochondrial disease
- BRIX1 Promotes Hepatocellular Carcinoma Progression via the MAPK/ERK Pathway and Serves as a Prognostic Biomarker
BibTeX
@article{yuan2026pancancer,
title = {{Pan-Cancer Analysis Identifies LUC7L2 as a Prognostic Biomarker and Potential Functional Regulator of Prostate Cancer Progression}},
author = {Jialin Yuan and Ping Zhan and Jun Liu and Guangming Lu and Han Wang and Meiqin Xiao and Dandan Li},
journal = {Biomedicines},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13702000},
note = {CC BY},
}
RIS
TY - JOUR
TI - Pan-Cancer Analysis Identifies LUC7L2 as a Prognostic Biomarker and Potential Functional Regulator of Prostate Cancer Progression
AU - Jialin Yuan
AU - Ping Zhan
AU - Jun Liu
AU - Guangming Lu
AU - Han Wang
AU - Meiqin Xiao
AU - Dandan Li
PY - 2026
DA - 2026/10/01
JO - Biomedicines
UR - https://europepmc.org/article/PMC/PMC13702000
SN - 2227-9059
ER -